Profil Penggunaan Obat Tuberculosis Multi Drug Resistant (Mdr) Di Rsud Dr. Moewardi Surakarta, Jawa Tengah
Aulia Fitri,
Zulmai Rani,
Robiatun Rambe
et al.
Abstract:Tuberkulosis Multi Drug Resistant (TB MDR) adalah TB yang disebabkan oleh resistensi kuman tuberkulosis terhadap dua jenis obat anti tuberkulosis (OAT) lini pertama, isoniazid dan rifampisin, baik bersamaan dengan atau tanpa OAT tambahan. Secara global insiden kasus TB MDR pada tahun 2016 berkisar 153.000 pasien dan diantaranya ada 130.000 pasien baru yang memulai pengobatan TB MDR di tahun tersebut, sedangkan keberhasilan terapi TB MDR terhadap pasien yang memulai pengobatan sejak 2014 sebanyak 54%. Total kas… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.